81 related articles for article (PubMed ID: 7466739)
1. Predictive value of decreasing antithrombin III in deep-vein thrombosis.
Andreasen TL
Thromb Haemost; 1980 Dec; 44(3):135-7. PubMed ID: 7466739
[TBL] [Abstract][Full Text] [Related]
2. On the significance of antithrombin-III, alpha 2-macroglobulin, alpha 2-antiplasmin, histidine-rich glycoprotein, and protein C in patients with acute myocardial infarction and deep vein thrombosis.
Gram J; Jespersen J
Thromb Haemost; 1985 Aug; 54(2):503-5. PubMed ID: 2417353
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
Chamontin B; Guittard J; Laroche M; Boneu B; Salvador M
Arch Mal Coeur Vaiss; 1984 Sep; 77(9):1064-7. PubMed ID: 6435583
[TBL] [Abstract][Full Text] [Related]
4. Involvement of dysplasminogenemia in occurrence of deep vein thrombosis.
Kawasaki T; Kambayashi J; Uemura Y; Sakon M; Shiba E; Suehisa E; Amino N; Mori T
Int Angiol; 1995 Mar; 14(1):65-8. PubMed ID: 7658107
[TBL] [Abstract][Full Text] [Related]
5. The rapid whole blood agglutination d-dimer assay has poor sensitivity for use as an exclusion test in suspected deep vein thrombosis.
Harper P; Marson C; Grimmer A; Monahan K; Humm G; Baker B
N Z Med J; 2001 Feb; 114(1126):61-4. PubMed ID: 11280427
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis.
Ginsberg JS; Siragusa S; Douketis J; Johnston M; Moffat K; Stevens P; Brill-Edwards P; Panju A; Patel A
Thromb Haemost; 1995 Sep; 74(3):833-6. PubMed ID: 8571306
[TBL] [Abstract][Full Text] [Related]
8. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
10. beta-thromboglobulin and deep vein thrombosis.
Smith RC; Duncanson J; Ruckley CV; Webber RG; Allan NC; Dawes J; Bolton AE; Hunter WM; Pepper DS; Cash JD
Thromb Haemost; 1978 Apr; 39(2):338-45. PubMed ID: 79229
[TBL] [Abstract][Full Text] [Related]
11. [Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients].
Sun KK; Wang C; Pang BS; Yang YH; He W; Chen TF; Zhao QH; Zhang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1019-23. PubMed ID: 15769354
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the accuracy of impedance plethysmography and compression ultrasonography in outpatients with clinically suspected deep vein thrombosis. A two centre paired-design prospective trial.
Wells PS; Hirsh J; Anderson DR; Lensing AW; Foster G; Kearon C; Weitz J; Cogo A; Prandoni P; Minuk T
Thromb Haemost; 1995 Dec; 74(6):1423-7. PubMed ID: 8772213
[TBL] [Abstract][Full Text] [Related]
13. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis.
Ginsberg JS; Wells PS; Hirsh J; Panju AA; Patel MA; Malone DE; McGinnis J; Stevens P; Brill-Edwards P
Arch Intern Med; 1994 Sep; 154(17):1930-3. PubMed ID: 8074596
[TBL] [Abstract][Full Text] [Related]
15. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.
Bertram B; Remky A; Arend O; Wolf S; Reim M
Ger J Ophthalmol; 1995 Nov; 4(6):332-5. PubMed ID: 8751097
[TBL] [Abstract][Full Text] [Related]
16. Leg vein thrombosis diagnosed by 125I-fibrinogen test after acute myocardial infarction.
Kotilainen M; Ristola P; Ikkala E; Pyörälä K
Ann Clin Res; 1973 Dec; 5(6):365-8. PubMed ID: 4792200
[No Abstract] [Full Text] [Related]
17. Diagnostic tests for deep vein thrombosis. Clinical usefulness depends on probability of disease.
Wheeler HB; Hirsh J; Wells P; Anderson FA
Arch Intern Med; 1994 Sep; 154(17):1921-8. PubMed ID: 8074595
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
[TBL] [Abstract][Full Text] [Related]
19. Clinical prediction of deep vein thrombosis in patients with leg symptoms.
Kahn SR; Joseph L; Abenhaim L; Leclerc JR
Thromb Haemost; 1999 Mar; 81(3):353-7. PubMed ID: 10102459
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of a screening protocol to exclude deep vein thrombosis on the basis of a combination of quantitative D-dimer testing and pretest clinical probability score.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Am Coll Surg; 2005 Nov; 201(5):701-9. PubMed ID: 16256912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
